A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of the study is to characterize the PK of single doses of salbutamol in healthy participants delivered via an MDI containing propellant HFA-152a (test), and to compare with an MDI containing propellant HFA-134a (reference).
Epistemonikos ID: aec542fb0c10b443ff949f74afe0b9738cf69f77
First added on: Jun 01, 2024